{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:41:33Z","timestamp":1793241693998,"version":"4.5.0"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Exosomes, lipid bilayer-enclosed small cellular vesicles, are actively secreted by various cells and play crucial roles in intercellular communication. These nanosized vesicles transport internalized proteins, mRNA, miRNA, and other bioactive molecules. Recent findings have provided compelling evidence that exosomes derived from stem cells hold great promise as a therapeutic modality for central nervous system disorders. These exosomes exhibit multifaceted properties including anti-apoptotic, anti-inflammatory, neurogenic, and vasculogenic effects. Furthermore, exosomes offer several advantages over stem cell therapy, such as high preservation capacity, low immunogenicity, the ability to traverse the blood-brain barrier, and the potential for drug encapsulation. Consequently, researchers have turned their attention to exosomes as a novel therapeutic avenue. Nonetheless, akin to the limitations of stem cell treatment, the limited accumulation of exosomes in the injured brain poses a challenge to their clinical application. To overcome this hurdle, intranasal administration has emerged as a non-invasive and efficacious route for delivering drugs to the central nervous system. By exploiting the olfactory and trigeminal nerve axons, this approach enables the direct transport of therapeutics to the brain while bypassing the blood-brain barrier. Notably, exosomes, owing to their small size, can readily access the nerve pathways using this method. As a result, intranasal administration has gained increasing recognition as an optimal therapeutic strategy for exosome-based treatments. In this comprehensive review, we aim to provide an overview of both basic and clinical research studies investigating the intranasal administration of exosomes for the treatment of central nervous system diseases. Furthermore, we elucidate the underlying therapeutic mechanisms and offer insights into the prospect of this approach.<\/jats:p>","DOI":"10.4103\/1673-5374.385875","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T01:00:15Z","timestamp":1695603615000},"page":"1249-1255","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":71,"title":["Intranasal administration of stem cell-derived exosomes for central nervous system diseases"],"prefix":"10.4103","volume":"19","author":[{"given":"Shuho","family":"Gotoh","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Hokkaido, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3574-8380","authenticated-orcid":false,"given":"Masahito","family":"Kawabori","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Hokkaido, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Fujimura","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Hokkaido, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,9,22]]},"reference":[{"key":"R1-20250925","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.3390\/ijms21103651","article-title":"ASC-exosomes ameliorate the disease progression in SOD1 (G93A) murine model underlining their potential therapeutic use in human ALS","volume":"21","author":"Bonafede","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R2-20250925","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1227\/NEU.0000000000001432","article-title":"Guidelines for the management of severe traumatic brain injury fourth edition","volume":"80","author":"Carney","year":"2017","journal-title":"Neurosurgery"},{"key":"R3-20250925","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0003-9993(97)90252-5","article-title":"Acute predictors of successful return to work 1 year after traumatic brain injury:a multicenter analysis","volume":"78","author":"Cifu","year":"1997","journal-title":"Arch Phys Med Rehabil"},{"key":"R4-20250925","doi-asserted-by":"crossref","first-page":"8129","DOI":"10.7150\/thno.62069","article-title":"Mesenchymal stem cell-derived extracellular vesicles ameliorate Alzheimer's disease-like phenotypes in a preclinical mouse model","volume":"11","author":"Cone","year":"2021","journal-title":"Theranostics"},{"key":"R5-20250925","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fncel.2018.00078","article-title":"Epigenetics and autism spectrum disorder:is there a correlation?","volume":"12","author":"Eshraghi","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"R6-20250925","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/adb.12675","article-title":"Intranasal delivery of mesenchymal stem cell-derived exosomes reduces oxidative stress and markedly inhibits ethanol consumption and post-deprivation relapse drinking","volume":"24","author":"Ezquer","year":"2019","journal-title":"Addict Biol"},{"key":"R7-20250925","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.tics.2011.07.003","article-title":"Genetics of autism spectrum disorders","volume":"15","author":"Geschwind","year":"2011","journal-title":"Trends Cogn Sci"},{"key":"R8-20250925","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13287-023-03264-0","article-title":"Mesenchymal stromal cell-derived secretome-based therapy for neurodegenerative diseases:overview of clinical trials","volume":"14","author":"Ghasemi","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"R9-20250925","doi-asserted-by":"crossref","first-page":"10015","DOI":"10.1021\/acsnano.9b01892","article-title":"Intranasal delivery of mesenchymal stem cell derived exosomes loaded with phosphatase and tensin homolog siRNA repairs complete spinal cord injury","volume":"13","author":"Guo","year":"2019","journal-title":"ACS Nano"},{"key":"R10-20250925","doi-asserted-by":"crossref","first-page":"11211","DOI":"10.3390\/ijms231911211","article-title":"Mesenchymal stem cell-derived extracellular vesicles as proposed therapy in a rat model of cerebral small vessel disease","volume":"23","author":"Guy","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R11-20250925","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s12975-015-0444-4","article-title":"Extending the time window for endovascular and pharmacological reperfusion","volume":"7","author":"Henninger","year":"2016","journal-title":"Transl Stroke Res"},{"key":"R12-20250925","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/stem.3456","article-title":"Intranasal delivery of mesenchymal stem cells-derived extracellular vesicles for the treatment of neurological diseases","volume":"39","author":"Herman","year":"2021","journal-title":"Stem Cells"},{"key":"R13-20250925","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.biocel.2016.09.002","article-title":"Curcumin-loaded embryonic stem cell exosomes restored neurovascular unit following ischemia-reperfusion injury","volume":"79","author":"Kalani","year":"2016","journal-title":"Int J Biochem Cell Biol"},{"key":"R14-20250925","doi-asserted-by":"crossref","first-page":"7380","DOI":"10.3390\/ijms21197380","article-title":"Clinical trials of stem cell therapy for cerebral ischemic stroke","volume":"21","author":"Kawabori","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R15-20250925","doi-asserted-by":"crossref","first-page":"e1202","DOI":"10.1212\/WNL.0000000000011450","article-title":"Cell therapy for chronic tbi:interim analysis of the randomized controlled STEMTRA trial","volume":"96","author":"Kawabori","year":"2021","journal-title":"Neurology"},{"key":"R16-20250925","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1080\/03007995.2022.2141482","article-title":"Cell therapies for acute and chronic traumatic brain injury","volume":"38","author":"Kawabori","year":"2022","journal-title":"Curr Med Res Opin"},{"key":"R17-20250925","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3390\/ijms21010181","article-title":"Intranasally administered human MSC-derived extracellular vesicles pervasively incorporate into neurons and microglia in both intact and status epilepticus injured forebrain","volume":"21","author":"Kodali","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R18-20250925","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/j.1349-7006.2010.01650.x","article-title":"Circulating microRNA in body fluid:a new potential biomarker for cancer diagnosis and prognosis","volume":"101","author":"Kosaka","year":"2010","journal-title":"Cancer Sci"},{"key":"R19-20250925","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.2174\/1381612824666180604111806","article-title":"Current perspectives regarding stem cell-based therapy for ischemic stroke","volume":"24","author":"Kwak","year":"2018","journal-title":"Curr Pharm Des"},{"key":"R20-20250925","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s41232-023-00274-6","article-title":"Extracellular vesicles from immortalized mesenchymal stromal cells protect against neonatal hypoxic-ischemic brain injury","volume":"43","author":"Labusek","year":"2023","journal-title":"Inflamm Regen"},{"key":"R21-20250925","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000522644","article-title":"Intranasal administration of extracellular vesicles mitigates apoptosis in a mouse model of neonatal hypoxic-ischemic brain injury","volume":"119","author":"Lawson","year":"2022","journal-title":"Neonatology"},{"key":"R22-20250925","doi-asserted-by":"crossref","first-page":"579162","DOI":"10.3389\/fncel.2020.579162","article-title":"Kinematic changes in a mouse model of penetrating hippocampal injury and their recovery after intranasal administration of endometrial mesenchymal stem cell-derived extracellular vesicles","volume":"14","author":"Leon-Moreno","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"R23-20250925","doi-asserted-by":"crossref","first-page":"6384","DOI":"10.1021\/acsabm.0c00831","article-title":"Mesenchymal stem cell-derived exosomes for treatment of autism spectrum disorder","volume":"3","author":"Liang","year":"2020","journal-title":"ACS Appl Bio Mater"},{"key":"R24-20250925","first-page":"460","article-title":"Some observations on the course of events after severe injury of the head. Hunterian Lecture delivered at the Royal College of Surgeons of England on 12th January 1967","volume":"41","author":"London","year":"1967","journal-title":"Ann R Coll Surg Engl"},{"key":"R25-20250925","doi-asserted-by":"crossref","first-page":"E3536","DOI":"10.1073\/pnas.1703920114","article-title":"Intranasal MSC-derived A1-exosomes ease inflammation and prevent abnormal neurogenesis and memory dysfunction after status epilepticus","volume":"114","author":"Long","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R26-20250925","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/sctm.19-0327","article-title":"Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer's disease","volume":"9","author":"Losurdo","year":"2020","journal-title":"Stem Cells Transl Med"},{"key":"R27-20250925","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jconrel.2020.09.019","article-title":"ADSCs-derived extracellular vesicles alleviate neuronal damage promote neurogenesis and rescue memory loss in mice with Alzheimer's disease","volume":"327","author":"Ma","year":"2020","journal-title":"J Control Release"},{"key":"R28-20250925","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41556-018-0250-9","article-title":"Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication","volume":"21","author":"Mathieu","year":"2019","journal-title":"Nat Cell Biol"},{"key":"R29-20250925","doi-asserted-by":"crossref","first-page":"105173","DOI":"10.1016\/j.neuint.2021.105173","article-title":"Intranasal delivery of exosomes from human adipose derived stem cells at forty-eight hours post injury reduces motor and cognitive impairments following traumatic brain injury","volume":"150","author":"Moss","year":"2021","journal-title":"Neurochem Int"},{"key":"R30-20250925","doi-asserted-by":"crossref","first-page":"e472","DOI":"10.1542\/peds.113.5.e472","article-title":"The genetics of autism","volume":"113","author":"Muhle","year":"2004","journal-title":"Pediatrics"},{"key":"R31-20250925","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10571-020-00865-8","article-title":"Time-dependent memory and gait improvement by intranasally-administered extracellular vesicles in Parkinson's disease model rats","volume":"41","author":"Narbute","year":"2021","journal-title":"Cell Mol Neurobiol"},{"key":"R32-20250925","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/sctm.18-0162","article-title":"Intranasal administration of extracellular vesicles derived from human teeth stem cells improves motor symptoms and normalizes tyrosine hydroxylase expression in the substantia nigra and striatum of the 6-hydroxydopamine-treated rats","volume":"8","author":"Narbute","year":"2019","journal-title":"Stem Cells Transl Med"},{"key":"R33-20250925","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/stmcls\/sxab026","article-title":"Neural stem cell-derived extracellular vesicles counteract insulin resistance-induced senescence of neurogenic niche","volume":"40","author":"Natale","year":"2022","journal-title":"Stem Cells"},{"key":"R34-20250925","doi-asserted-by":"crossref","first-page":"e14296","DOI":"10.1111\/nmo.14296","article-title":"Digital health for functional gastrointestinal disorders","volume":"35","author":"Pathipati","year":"2023","journal-title":"Neurogastroenterol Motil"},{"key":"R35-20250925","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1021\/acsnano.1c08473","article-title":"Intranasal administration of self-oriented nanocarriers based on therapeutic exosomes for synergistic treatment of Parkinson's disease","volume":"16","author":"Peng","year":"2022","journal-title":"ACS Nano"},{"key":"R36-20250925","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13229-018-0240-6","article-title":"Intranasal administration of exosomes derived from mesenchymal stem cells ameliorates autistic-like behaviors of BTBR mice","volume":"9","author":"Perets","year":"2018","journal-title":"Mol Autism"},{"key":"R37-20250925","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1021\/acs.nanolett.8b04148","article-title":"Golden exosomes selectively target brain pathologies in neurodegenerative and neurodevelopmental disorders","volume":"19","author":"Perets","year":"2019","journal-title":"Nano Lett"},{"key":"R38-20250925","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13229-020-00366-x","article-title":"Exosomes derived from mesenchymal stem cells improved core symptoms of genetically modified mouse model of autism Shank3B","volume":"11","author":"Perets","year":"2020","journal-title":"Mol Autism"},{"key":"R39-20250925","doi-asserted-by":"crossref","first-page":"12860","DOI":"10.3390\/ijms222312860","article-title":"Functional recovery caused by human adipose tissue mesenchymal stem cell-derived extracellular vesicles administered 24 h after stroke in rats","volume":"22","author":"Rohden","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R40-20250925","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1161\/STROKEAHA.110.601914","article-title":"Stem cell therapy as an emerging paradigm for stroke (STEPS) II","volume":"42","author":"Savitz","year":"2011","journal-title":"Stroke"},{"key":"R41-20250925","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3389\/fphys.2019.00282","article-title":"Mesenchymal stromal cell derived extracellular vesicles reduce hypoxia-ischaemia induced perinatal brain injury","volume":"10","author":"Sisa","year":"2019","journal-title":"Front Physiol"},{"key":"R42-20250925","doi-asserted-by":"crossref","first-page":"8994","DOI":"10.3390\/ijms21238994","article-title":"Neural stem cell-derived exosomes revert HFD-dependent memory impairment via CREB-BDNF signalling","volume":"21","author":"Spinelli","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R43-20250925","doi-asserted-by":"crossref","first-page":"9636897231158153","DOI":"10.1177\/09636897231158153","article-title":"Stem cell therapies for intracerebral hemorrhage:review of preclinical and clinical studies","volume":"32","author":"Takamiya","year":"2023","journal-title":"Cell Transplant"},{"key":"R44-20250925","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13287-019-1207-z","article-title":"Exosomes derived from umbilical cord mesenchymal stem cells reduce microglia-mediated neuroinflammation in perinatal brain injury","volume":"10","author":"Thomi","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"R45-20250925","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3390\/cells8080855","article-title":"Intranasally administered exosomes from umbilical cord stem cells have preventive neuroprotective effects and contribute to functional recovery after perinatal brain injury","volume":"8","author":"Thomi","year":"2019","journal-title":"Cells"},{"key":"R46-20250925","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.cell.2016.01.043","article-title":"Communication by extracellular vesicles:where we are and where we need to go","volume":"164","author":"Tkach","year":"2016","journal-title":"Cell"},{"key":"R47-20250925","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3390\/pharmaceutics15020548","article-title":"Biodistribution of intratracheal intranasal and intravenous injections of human mesenchymal stromal cell-derived extracellular vesicles in a mouse model for drug delivery studies","volume":"15","author":"Tolomeo","year":"2023","journal-title":"Pharmaceutics"},{"key":"R48-20250925","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.seizure.2016.11.001","article-title":"25 years of advances in the definition classification and treatment of status epilepticus","volume":"44","author":"Trinka","year":"2017","journal-title":"Seizure"},{"key":"R49-20250925","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41398-020-00988-y","article-title":"Mesenchymal stem cells derived extracellular vesicles improve behavioral and biochemical deficits in a phencyclidine model of schizophrenia","volume":"10","author":"Tsivion-Visbord","year":"2020","journal-title":"Transl Psychiatry"},{"key":"R50-20250925","doi-asserted-by":"crossref","first-page":"5345","DOI":"10.7150\/ijbs.73747","article-title":"Mesenchymal stromal cell-derived extracellular vesicles afford neuroprotection by modulating PI3K\/AKT pathway and calcium oscillations","volume":"18","author":"Turovsky","year":"2022","journal-title":"Int J Biol Sci"},{"key":"R51-20250925","doi-asserted-by":"crossref","first-page":"1809064","DOI":"10.1080\/20013078.2020.1809064","article-title":"Extracellular vesicles from human iPSC-derived neural stem cells:miRNA and protein signatures and anti-inflammatory and neurogenic properties","volume":"9","author":"Upadhya","year":"2020","journal-title":"J Extracell Vesicles"},{"key":"R52-20250925","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat Cell Biol"},{"key":"R53-20250925","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1586\/14737175.2015.1079130","article-title":"Immunity and inflammation in status epilepticus and its sequelae:possibilities for therapeutic application","volume":"15","author":"Vezzani","year":"2015","journal-title":"Expert Rev Neurother"},{"key":"R54-20250925","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ijdevneu.2011.02.012","article-title":"The developing oligodendrocyte:key cellular target in brain injury in the premature infant","volume":"29","author":"Volpe","year":"2011","journal-title":"Int J Dev Neurosci"},{"key":"R55-20250925","doi-asserted-by":"crossref","first-page":"18327","DOI":"10.1021\/acsnano.1c07587","article-title":"A microfluidics-based scalable approach to generate extracellular vesicles with enhanced therapeutic microRNA loading for intranasal delivery to mouse glioblastomas","volume":"15","author":"Wang","year":"2021","journal-title":"ACS Nano"},{"key":"R56-20250925","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12951-023-01862-x","article-title":"Anti-CHAC1 exosomes for nose-to-brain delivery of miR-760-3p in cerebral ischemia\/reperfusion injury mice inhibiting neuron ferroptosis","volume":"21","author":"Wang","year":"2023","journal-title":"J Nanobiotechnology"},{"key":"R57-20250925","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2015.10.017","article-title":"Effect of exosome isolation methods on physicochemical properties of exosomes and clearance of exosomes from the blood circulation","volume":"98","author":"Yamashita","year":"2016","journal-title":"Eur J Pharm Biopharm"},{"key":"R58-20250925","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.3390\/ijms21113994","article-title":"Clinical trials of stem cell treatment for spinal cord injury","volume":"21","author":"Yamazaki","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R59-20250925","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1039\/D2BM00518B","article-title":"High-efficiency brain-targeted intranasal delivery of BDNF mediated by engineered exosomes to promote remyelination","volume":"10","author":"Zhai","year":"2022","journal-title":"Biomater Sci"},{"key":"R60-20250925","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2023.03.033","article-title":"Intranasal delivery of BDNF-loaded small extracellular vesicles for cerebral ischemia therapy","volume":"357","author":"Zhou","year":"2023","journal-title":"J Control Release"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.385875","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:45:40Z","timestamp":1787067940000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.385875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,22]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/1673-5374.385875","relation":{},"ISSN":["1673-5374","1876-7958"],"issn-type":[{"value":"1673-5374","type":"print"},{"value":"1876-7958","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,22]]},"assertion":[{"value":"2023-06-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}